In an analysis of model performance for predicting OS, the model had a C-index value of 0.789, compared with C-index values for the other models of 0.650 with the IPS-3, 0.608 with the IPS-7, and ...

Source: Getty Images Experts recommend that patients with advanced cancer be referred to specialized interdisciplinary palliative care teams soon after diagnosis. To develop updated recommendations ...

Using Grey’s self-management theory domains, they shortlisted the tasks the app should support to include make daily health reports, learn weekly health trends, provide schedule reminders, and share ...

(HealthDay News) — For adults who are not up to date with colorectal cancer screening, offering a choice of colonoscopy or fecal immunochemical testing (FIT) increases screening completion rates, ...

Obliteration of normal renal parenchyma by kidney cancer is associated with worse oncologic outcomes, according to a recent study. The study of 1122 patients with nonmetastatic renal cell carcinoma ...

Minimal residual disease negativity at baseline, before maintenance, and 1 year after transplant was associated with improved progression-free survival at 6 years, 5 years, and 3 years, respectively.

The rate of mammography completion in the United States is below the target of 80.5% set by the Healthy People 2030 targets. A text message intervention increased mammogram completion rates in 2 ...

(HealthDay News) — A multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance, and ...

One strategy is to spread the SDM process over multiple consultations, encouraging the patient to take time to process information and to engage them in conversation about their thought processes. The ...

(HealthDay News) — For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study published online May 16 in ...

At a median follow-up of 25.4 months, the median event-free survival was not reached in the nivolumab arm and was 18.4 months in the control arm. Adding perioperative nivolumab to neoadjuvant ...

Recent studies have reported that opioid use was negatively associated with survival among ICI recipients. However, the mechanism of this relationship remains unclear. Opioid use while receiving ...